Integra LifeSciences Holdings Corporation (Nasdaq:IART) has scheduled a conference call for 9:00 AM ET on Monday, May 9 to discuss financial results for the first quarter ended March 31, 2005 and to update forward-looking financial guidance. Financial results for the first quarter 2005 will be announced via a news release issued on May 8.
The conference call will be hosted by Stuart Essig, President and Chief Executive Officer of Integra, and will be open to all listeners. Additional forward- looking information may be discussed in a question and answer session following the call.
Access to the live call is available by dialing 973-935- 8511 or through a webcast via a link provided on Integra's website at www.Integra-LS.com. Access to a replay is available through May 23, 2005 by dialing 973- 341-3080 (PIN 5937953) or through the webcast.
Integra LifeSciences Holdings Corporation is a diversified medical technology company that develops, manufactures, and markets medical devices for use in a variety of applications. The primary applications for Integra's products are neuro-trauma and neurosurgery, reconstructive surgery and general surgery. Integra is a leader in applying the principles of biotechnology to medical devices that improve patients' quality of life. Our corporate headquarters are in Plainsboro, New Jersey, and we have manufacturing and research facilities located throughout the world.
Integra LifeSciences Holdings Corporation
Maria Platsis, 609-936-2333